Mucocutaneous manifestations of Epstein-Barr virus infection

Miniatura

Archivos

Mendoza_Natalia_2008.pdf (2.16 MB)

Fecha

2008

Autores

Título de la revista

Publicado en

American Journal of Clinical Dermatology, 1179-1888, Vol. 9, Nro. 5, 2008 p. 295-305

Publicado por

Springer Link

URI

https://hdl.handle.net/20.500.12495/4677

URL de la fuente

https://link.springer.com/article/10.2165/00128071-200809050-00003

Enlace a contenidos multimedia

ISSN de la revista

Título del volumen

Resumen

Descripción

Abstract

This review focuses on Epstein-Barr virus (EBV) infection, diagnosis, and current treatment, with emphasis on EBV-associated mucocutaneous manifestations in primary infections, acute EBV-associated syndromes, chronic infections, lymphoproliferative disorders, and lymphomas. In primary infection, EBV infects B cells and can cause mucocutaneous manifestations in infectious mononucleosis or acute EBV-associated syndromes such as Gianotti-Crosti syndrome and hemophagocytic syndrome. EBV then persists in the majority of humans generally without causing disease. In some cases, however, latent EBV infection may result in diseases such as hydroa vacciniforme, hypersensitivity to mosquito bites, and lymphoproliferative disorders such as plasmablastic lymphoma, oral hairy leukoplakia, and post-transplant lymphoproliferative disorders, particularly in immunocompromised patients. Latent EBV infection has also been implicated in a variety of malignant conditions such as Burkitt lymphoma, Hodgkin lymphoma, nasopharyngeal carcinoma, and Kikuchi histocytic necrotizing lymphadenitis. Since the immune system is critical in preventing the progression of EBV disease, the immunologic status of the patient plays a crucial role in the subsequent development of pathologies.

Palabras clave

Keywords

Temáticas

Síndrome mucocutáneo linfonodular
Epstein-Barr
Infecciones

Citación

Colecciones

Artículos